
SBC Medical Group Holdings Incorporated: shareholders and insiders
Price
$6.18
November 16, 2026Market cap $634M
What Ploutos Investor adds for SBC Medical Group
Part of Ploutos Investor, €9.99 a month
- The full history: 3 fiscal years, from 2023
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 17, 2025 to –, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$20M
1 person
From Nov 17, 2025 to Nov 17, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
- Apr 28, 2026Yoshiyuki AikawaChairman and CEOKind
- Apr 21, 2026Yoshiyuki AikawaChairman and CEOKind
- Mar 6, 2026Yoshiyuki AikawaChairman and CEOKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Apr 28, 2026 | Yoshiyuki AikawaChairman and CEO | 465.0K | $3.02 | $1.4M | Form 4 | |
| Apr 21, 2026 | Yoshiyuki AikawaChairman and CEO | 3.10M | $3.02 | $9.4M | Form 4 | |
| Mar 6, 2026 | Yoshiyuki AikawaChairman and CEO | 4.42M | $2.12 | $9.4M | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before – the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by SBC's officers and directors from 2022 up to November 16, 2025, 4 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
Yoshiyuki Aikawa82.2%From the filing of Apr 21, 2026
Item 4 of the Schedule 13D is hereby amended and restated as set forth below: On April 19, 2026, the Reporting Person, as a selling stockholder and the Issuer entered into an underwriting agreement (the "Underwriting Agreement") with Maxim Group LLC, as representative of the underwriters named therein (the "Underwriters"), relating to an underwritten offering of 3,100,000 shares of Common Stock (the "Offering"). The Underwriters purchased the shares of Common Stock from the Reporting Person at a net price of $3.0225 per share. Additionally, pursuant to the Underwriting Agreement, the Reporting Person has granted the Underwriters a 45-day option to purchase up to an additional 465,000…
From the filing of Apr 21, 2026
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter
- AQR CapitalIn the quarter+92%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 144.7K | $400.0K | 0.00% | |
| AQR Capital | 24.1K | +92% | $100.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 0.73% of its shares outstanding were held short, -7.8% since the report before.
- Shares held short
- 750.8K
- 0.73%
- Since the report before813.9K on Sep 30, 2026
- -7.8%
- 3.9
- 192.2K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 47%
- Report date
- Oct 15, 2026
- Shares held short
- Sep 30, 2024: Shares held short 30.6K
- Oct 15, 2024: Shares held short 31.7K
- Oct 31, 2024: Shares held short 30.4K
- Nov 15, 2024: Shares held short 31.3K
- Nov 29, 2024: Shares held short 16.8K
- Dec 13, 2024: Shares held short 22.4K
- Dec 31, 2024: Shares held short 36.5K
- Jan 15, 2025: Shares held short 31.8K
- Jan 31, 2025: Shares held short 30.4K
- Feb 14, 2025: Shares held short 23.6K
- Feb 28, 2025: Shares held short 27.1K
- Mar 14, 2025: Shares held short 58.6K
- Mar 31, 2025: Shares held short 28.1K
- Apr 15, 2025: Shares held short 70.8K
- Apr 30, 2025: Shares held short 24.1K
- May 15, 2025: Shares held short 34.1K
- May 30, 2025: Shares held short 78.6K
- Jun 13, 2025: Shares held short 31.4K
- Jun 30, 2025: Shares held short 222.6K
- Jul 15, 2025: Shares held short 224.3K
- Jul 31, 2025: Shares held short 214.0K
- Aug 15, 2025: Shares held short 189.8K
- Aug 29, 2025: Shares held short 177.1K
- Sep 15, 2025: Shares held short 133.5K
- Sep 30, 2025: Shares held short 140.6K
- Oct 15, 2025: Shares held short 126.1K
- Oct 31, 2025: Shares held short 96.8K
- Nov 14, 2025: Shares held short 113.7K
- Nov 28, 2025: Shares held short 144.5K
- Dec 15, 2025: Shares held short 143.7K
- Dec 31, 2025: Shares held short 401.3K
- Jan 15, 2026: Shares held short 302.6K
- Jan 30, 2026: Shares held short 338.6K
- Feb 13, 2026: Shares held short 354.9K
- Feb 27, 2026: Shares held short 327.8K
- Mar 13, 2026: Shares held short 307.3K
- Mar 31, 2026: Shares held short 231.1K
- Apr 15, 2026: Shares held short 338.4K
- Apr 30, 2026: Shares held short 312.1K
- May 15, 2026: Shares held short 273.4K
- May 29, 2026: Shares held short 388.7K
- Jun 15, 2026: Shares held short 377.6K
- Jun 30, 2026: Shares held short 549.2K
- Jul 15, 2026: Shares held short 914.8K
- Jul 31, 2026: Shares held short 814.0K
- Aug 14, 2026: Shares held short 674.5K
- Aug 31, 2026: Shares held short 696.2K
- Sep 15, 2026: Shares held short 717.5K
- Sep 30, 2026: Shares held short 813.9K
- Oct 15, 2026: Shares held short 750.8K
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading53.0% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 53.0% of the shares in the reported trades were short sales, against 54.1% in the 14 before.
- Last 14 sessionsOct 28, 2026 – Nov 16, 2026
- 53.0%
- The 14 beforeOct 8, 2026 – Oct 27, 2026
- 54.1%
- Change
- -1.1 pts
- Short sales a dayon average, of 156.3K shares
- 82.8K
- More than atof 3,668 US-listed companies, same days
- 60%
- Median of alleight in ten from 34.7% to 63.8%
- 50.3%
- Short sales
- Oct 8, 2026: Short sales 46.5%
- Oct 9, 2026: Short sales 81.8%
- Oct 12, 2026: Short sales 52.9%
- Oct 13, 2026: Short sales 45.7%
- Oct 14, 2026: Short sales 47.3%
- Oct 15, 2026: Short sales 66.4%
- Oct 16, 2026: Short sales 61.5%
- Oct 19, 2026: Short sales 65.2%
- Oct 20, 2026: Short sales 69.7%
- Oct 21, 2026: Short sales 39.8%
- Oct 22, 2026: Short sales 29.1%
- Oct 23, 2026: Short sales 39.8%
- Oct 26, 2026: Short sales 67.7%
- Oct 27, 2026: Short sales 53.1%
- Oct 28, 2026: Short sales 58.3%
- Oct 29, 2026: Short sales 63.7%
- Oct 30, 2026: Short sales 56.7%
- Nov 2, 2026: Short sales 59.5%
- Nov 3, 2026: Short sales 41.1%
- Nov 4, 2026: Short sales 46.7%
- Nov 5, 2026: Short sales 29.5%
- Nov 6, 2026: Short sales 35.8%
- Nov 9, 2026: Short sales 51.9%
- Nov 10, 2026: Short sales 62.1%
- Nov 11, 2026: Short sales 28.9%
- Nov 12, 2026: Short sales 52.8%
- Nov 13, 2026: Short sales 50.4%
- Nov 16, 2026: Short sales 60%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
A lower bound: it counts only the 2 officers and directors with a market trade since Nov 18, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 269 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWNiShares Russell 2000 Value ETFWeight in the fund0.00%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.00%
- IWMiShares Russell 2000 ETFWeight in the fund0.00%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
4 of the 269 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 42
- Q4 2025: Managers 42
- Q1 2026: Managers 50
- Q2 2026: Managers 57
Institutional investors by quarter
The fund managers holding SBC, quarter by quarter, from Q3 2022 to Q2 2025, 12 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 57 managers held 4.40M shares, worth $14M. During the quarter 13 opened a position, 6 closed one, 32 added and 6 trimmed.
The largest holders, Q2 2026
- Lumbard & KellnerIn the quarter×100.0
- BlackRockIn the quarter+120%
- Geode Capital ManagementIn the quarter+45%
- Citadel Advisors (Griffin)In the quarter
- Vanguard Capital ManagementIn the quarter-0.3%
- Northern TrustIn the quarter+44%
- Vanguard Portfolio ManagementIn the quarter+102%
- Hillsdale Investment ManagementIn the quarter
- Segall Bryant & HamillIn the quarter
- Vanguard Fiduciary TrustIn the quarter+6.1%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Lumbard & Kellner | 1.73M | ×100.0 | $5.3M |
| BlackRock | 924.0K | +120% | $2.8M |
| Geode Capital Management | 427.9K | +45% | $1.3M |
| Citadel Advisors (Griffin) | 144.7K | $445.7K | |
| Vanguard Capital Management | 135.8K | -0.3% | $418.2K |
| Northern Trust | 131.2K | +44% | $404.1K |
| Vanguard Portfolio Management | 128.3K | +102% | $395.1K |
| Hillsdale Investment Management | 124.8K | $384.4K | |
| Segall Bryant & Hamill | 81.3K | $250.4K | |
| Vanguard Fiduciary Trust | 66.3K | +6.1% | $204.1K |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do SBC Medical Group's filings show?
Who buys and sells is one part of SBC Medical Group's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have SBC's insiders bought or sold?
From – to – SBC Medical Group's insiders reported no purchase or sale of shares on the market.
Which well-known managers hold SBC?
2 of the managers we track held the shares on Jun 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $400.0K.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.